Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)

Digestive Diseases and Sciences

Volumn 57, Issue 7, 2012, Pages 1932-1941

  Volynets, Valentina ^a   Küper, Markus A ^b   Strahl, Stefan ^c   Maier, Ina B ^a   Spruss, Astrid ^a   Wagnerberger, Sabine ^a   Königsrainer, Alfred ^b   Bischoff, Stephan C ^a   Bergheim, Ina ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c KLINIKUM ESSLINGEN   (Germany)

Author keywords

Carbohydrate; Endotoxin; Ethanol; Intestinal barrier; PAI 1; Protein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE; DISACCHARIDE; ENDOTOXIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LACTULOSE; MANNITOL; MONOSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ARTICLE; BACTERIAL OVERGROWTH; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; OROCECAL TRANSIT TIME; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; TIME;

ADULT; CASE-CONTROL STUDIES; DIETARY CARBOHYDRATES; DIETARY PROTEINS; DISEASE PROGRESSION; ENDOTOXINS; ETHANOL; FATTY LIVER; FEMALE; HUMANS; INTESTINES; MALE; NUTRITIONAL STATUS; PERMEABILITY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84864193026     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2112-9     Document Type: Article

References (48)

1. Yang L, Bataller R, Dulyx J, et al. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol. 2005;43:317-323. (Pubitemid 40956886)
2. Adams LA, Lymp JF, St SJ, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-121. (Pubitemid 41002048)
3. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and nonalcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8-14. (Pubitemid 17045538)
4. Purohit V, Bode JC, Bode C, et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol. 2008;42:349-361.
5. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarhy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steato-hepatitis. Gut. 2001;48:206-211. (Pubitemid 32141844)
6. Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452-1455.
7. Soza A, Riquelme A, Gonzalez R, et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2005;50:1136-1140. (Pubitemid 40864023)
8. Harte AL, da Silva NF, Creely SJ, et al. Elevated endotoxin levels in nonalcoholic fatty liver disease. J Inflamm. 2010;7:15.
9. Farhadi A, Gundlapalli S, Shaikh M, et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in nonalcoholic steatohepatitis. Liver Int. 2008;28:1026-1033. (Pubitemid 352044451)
10. Ruiz AG, Casafont F, Crespo J, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of nonalcoholic steatohepatitis. Obes Surg. 2007;17: 1374-1380.
11. Nair S, Cope K, Risby TH, Diehl AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol. 2001;96:1200-1204. (Pubitemid 32319161)
12. Assy N, Nasser G, Kamayse I, et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008;22:811-816.
13. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for nonalcoholic fatty liver disease. J Hepatol. 2008; 48:993-999.
14. Solga S, Alkhuraishe AR, Clark JM, et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004;49:1578-1583. (Pubitemid 39335538)
15. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1961-1971.
16. Bergheim I, Weber S, Vos M, et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol. 2008;48:983-992.
17. Taylor KJ, Riely CA, Hammers L, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology. 1986;160:65-71. (Pubitemid 16090075)
18. Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the "bright liver"). Br J Radiol. 1979;52:184-188. (Pubitemid 9183403)
19. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26-31.
20. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
21. Landig J, Erhardt JG, Bode JC, Bode C. Validation and comparison of two computerized methods of obtaining a diet history. Clin Nutr. 1998;17:113-117. (Pubitemid 28349831)
22. Erhardt JG, Meisner C, Bode JC, Bode C. Lycopene, beta-carotene, and colorectal adenomas 23. Am J Clin Nutr. 2003;78: 1219-1224.
23. Generoso M, De RM, De RR, et al. Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;783:349-357. (Pubitemid 35447985)
24. Fleming SC, Kapembwa MS, Laker MF, Levin GE, Griffin GE. Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability. Clin Chem. 1990;36:797-799.
25. Pascual S, Such J, Esteban A, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology. 2003;50:1482-1486. (Pubitemid 37186515)
26. Parrilli G, Cuomo R, Nardone G, Maio G, Izzo CM, Budillon G. Investigation of intestine function during acute viral hepatitis using combined sugar oral loads. Gut. 1987;28:1439-1444. (Pubitemid 17164076)
27. Liu H, Zhang S, Yu A, et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett. 2004;14:2339-2344. (Pubitemid 38481417)
28. Cariello R, Federico A, Sapone A, et al. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis. 2010;42: 200-204.
29. Bonnichsen RK, Theorell H. An enzymatic method for the microdetermination of ethanol. Scand J Clin Lab Invest. 1951;3: 58-62.
30. Parlesak A, Klein B, Schecher K, Bode JC. bode C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003;51:768-773. (Pubitemid 36693425)
31. Miele L, Valenza V, La TG, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877-1887.
32. La Brooy SJ, Male PJ, Beavis AK, Misiewicz JJ. Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time. Gut. 1983;24:893-896. (Pubitemid 13009572)
33. Toshimitsu K, Matsuura B, Ohkubo I, et al. Dietary habits and nutrient intake in nonalcoholic steatohepatitis. Nutrition. 2007; 23:46-52. (Pubitemid 44959764)
34. Gill HK, Wu GY. Nonalcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? World J Gastroenterol. 2006;12:345-353. (Pubitemid 43329249)
35. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for nonalcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47:711-717. (Pubitemid 47503432)
36. Kang H, Greenson JK, Omo JT, et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol. 2006;101:2247-2253. (Pubitemid 44477551)
37. Yamamoto M, Iwasa M, Iwata K, et al. Restriction of dietary calories, fat and iron improves nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2007;22:498-503. (Pubitemid 46434977)
38. Ibrahim W, Lee US, Yeh CC, Szabo J, Bruckner G, Chow CK. Oxidative stress and antioxidant status in mouse liver: effects of dietary lipid, vitamin E and iron. 1656. J Nutr. 1997;127:1401-1406. (Pubitemid 27284011)
39. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology. 2000;119:1340-1347.
40. Logan BK, Jones AW. Endogenous ethanol production in a child with short gut syndrome. J Pediatr Gastroenterol Nutr. 2003;36:419-420.
41. McManus IR, Contag AO, Olson RE. Characterization of endogenous ethanol in the mammal. Science. 1960;131:102-103.
42. Baraona E, Julkunen R, Tannenbaum L, Lieber CS. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology. 1986;90:103-110. (Pubitemid 16211985)
43. Hanover LM, White JS. Manufacturing, composition, and applications of fructose. Am J Clin Nutr. 1993;58:724S-732S. (Pubitemid 23319969)
44. Mezey E, Imbembo AL, Potter JJ, Rent KC, Lombardo R, Holt RP. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am J Clin Nutr. 1975;28:1277-1283.
45. Hunnisett A, Howard J, Davies S. Gut fermentation (or autobrewery) syndrome. A new clinical test with initial observations and discussion of clinical and biological implications. J Nutr Med. 1990;1:33-38.
46. Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroent. 1979;14:333-336. (Pubitemid 9185710)
47. Alessi MC, Bastelica D, Mavri A, et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23:1262-1268. (Pubitemid 36873814)
48. Le KA, Bortolotti M. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2008;11:477-482.